rafal_olechowski Carisma Therapeutics (NASDAQ:CARM) climbed ~29% premarket Friday after the cell therapy developer said it would receive $2M for discovering a cancer drug candidate as part of a collaboration with Moderna (NASDAQ:MRNA). Nominating the first development candidate under the partnership, the company said that the unnamed drug targets Glypican-3, aContinue Reading
Maddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed mRESVIA, its vaccine targeted at the respiratory syncytial virus (RSV). Issuing a so-called positive opinion, EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended grantingContinue Reading
Peach_iStock Stock futures edged slightly higher on the last trading day of the second quarter, early Friday morning, as investors eagerly awaited U.S. inflation data due later today. Here are some of Friday’s biggest stock movers: Biggest stock gainers Infinera’s (NASDAQ:INFN) stock jumped over 25% after Nokia (NOK) announced itContinue Reading
Nexalin Technology (NASDAQ:NXL) announces the pricing of a public offering of 3 million shares of common stock at $1.75. The gross proceeds from the offering are expected to be approximately $5.25 million. The offering is expected to close on July 1, 2024. NXL stock fell 3.1% to $2.87 after-hours on Thursday. More onContinue Reading
Nutex Health (NASDAQ:NUTX) on Thursday announced a 1-for-10 reverse stock split of its common stock effective with the market opening on Wednesday, July 3. The reverse stock split will take effect on July 2, and the company’s common stock will open for trading on Nasdaq on July 3, on aContinue Reading
MicroStockHub X4 Pharmaceuticals (NASDAQ:XFOR) traded sharply lower on Thursday after the biotech updated data from an ongoing Phase 2 trial for its lead candidate mavorixafor in chronic neutropenia (CN), a rare blood disorder. Citing a May 24 data cut, the Boston, Massachusetts-based biotech said mavorixafor, which X4 (XFOR) markets asContinue Reading
Wall Street on Thursday continued to struggle for momentum, as a slide in Walgreens Boots Alliance (WBA) and Micron Technology (MU) capped gains. Meanwhile, U.S. Treasurys rebounded after a plethora of economic data lent support to a scenario where the Federal Reserve can start cutting interest rates. The benchmark S&PContinue Reading
JHVEPhoto/iStock Editorial via Getty Images Jefferies (NYSE:JEF) stock gapped up 7.6% in Thursday afternoon trading after delivering fiscal Q2 earnings that surpassed the average analyst estimate as positive momentum continued to build across its investment banking businesses. Q2 GAAP EPS of $0.64, topping the $0.63 Wall Street consensus, fell fromContinue Reading
BCFC/iStock Editorial via Getty Images Walgreens Boots Alliance (NASDAQ:WBA) announced a major round of store closures on Thursday as part of a company-wide strategic review, hurting the shares of its rival pharmacy chain CVS Health (NYSE:CVS) and pharmaceutical distributor Cencora (NYSE:COR). The announcement coincided with the drug store chain’s Q3Continue Reading
NISIT RAWO 2seventy bio (NASDAQ:TSVT) traded higher premarket Thursday after announcing the completion of an asset purchase agreement under which Novo Nordisk (NVO) (OTCPK:NONOF) has acquired its Hemophilia A program and rights to certain other assets. The staff members working in the program will also join the pharma giant asContinue Reading
